Browsing Tag
OVATION 3 trial
1 post
Why the IMNN-001 and PARP inhibitor pairing could matter more than the standalone data in ovarian cancer
IMNN-001 plus PARP inhibitors shows extended survival in ovarian cancer. Find out what this means for IMUNON Inc. and future treatment strategies.